11h
Johnson & Johnson Submits OTTAVA™ Robotic Surgical System to the U.S. Food and Drug Administration
Johnson & Johnson today announced that the company has submitted the OTTAVA™ Robotic Surgical System to the U.S. Food and Drug Administration (FDA) in an application for De Novo classification.
Surgery for refractory constipation should be a last resort, used only after comprehensive physiologic and psychological ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback